Mezzasalma Advisors, LLC

Position in JNJ — Johnson & Johnson

CIK 1864916 TINTON FALLS, NJ

Position in JNJ

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$266,668

+$6,095 QoQ

Shares Held

1,050

-1.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#4,290

of 4,676 holders

Holding Since

Dec 2020

19 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Mezzasalma Advisors, LLC holds $4,153,666 across 4 Drug Manufacturers - General names. JNJ ranks #4 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,883	$2,258,526
2	NVS	Novartis AG	6,965	$1,091,554
3	SNY	Sanofi	12,586	$536,918
4	JNJ	Johnson & Johnson This page	1,050	$266,668

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$266,668	1,050	-1.5%	Shares	Sole	2026-08-10
2026-03-31	$260,573	1,066	-2.3%	Shares	Sole	2026-04-17
2025-12-31	$225,782	1,091	-8.9%	Shares	Sole	2026-01-21
2025-09-30	$221,947	1,197	-11.1%	Shares	Sole	2025-10-16
2025-03-31	$223,220	1,346	-36.3%	Shares	Sole	2025-04-18
2024-03-31	$334,413	2,114	-15.3%	Shares	Sole	2024-04-19
2023-12-31	$391,066	2,495	-2.5%	Shares	Sole	2024-01-12
2023-09-30	$398,408	2,558	-0.0%	Shares	Sole	2023-11-16
2023-06-30	$423,565	2,559	+1.5%	Shares	Sole	2023-08-03
2023-03-31	$390,600	2,520	-24.1%	Shares	Sole	2023-05-15
2022-12-31	$586,478	3,320	-1.6%	Shares	Sole	2023-02-28
2022-09-30	$551,176	3,374	0.0%	Shares	Sole	2022-10-24
2022-06-30	$598,918	3,374	+32.7%	Shares	Sole	2022-07-13
2022-03-31	$450,695	2,543	+0.0%	Shares	Sole	2022-04-26
2021-12-31	$434,859	2,542	-20.4%	Shares	Sole	2022-01-31
2021-09-30	$515,992	3,195	+0.1%	Shares	Sole	2021-10-19
2021-06-30	$526,014	3,193	-9.3%	Shares	Sole	2021-07-14
2021-03-31	$578,347	3,519	-3.3%	Shares	Sole	2021-06-01
2020-12-31	$572,705	3,639	—	Shares	Sole	2021-06-01
No filing history on record for this holder in this stock.